Susquehanna International Group
NVNO

Susquehanna International Group’s enVVeno Medical NVNO Stock Holding History

Susquehanna International Group’s Portfolio NVNO Stock Details NVNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,377
Closed -$500K – 13666
2021
Q3 		$500K Buy
+1,377
New +$357K ﹤0.01% 9403

Other funds holding NVNO

KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Susquehanna International Group's NVNO Position: Q1 2026 in Review

Susquehanna International Group sold out of enVVeno Medical (NVNO) in Q1 2026, closing a stake of 3,781 shares — an estimated $42.5K sold.

Susquehanna International Group first reported a position in NVNO in Q3 2018 and held it in 11 quarters. The position peaked at $318K in Q3 2023. 17 funds tracked by Wall St. Rank hold NVNO as of Q1 2026.

  • Susquehanna International Group reported no remaining enVVeno Medical position as of Q1 2026 after selling out during the quarter.
  • Susquehanna International Group sold 3,781 enVVeno Medical shares in Q1 2026, an estimated $42.5K.
  • Susquehanna International Group first reported a position in enVVeno Medical in Q3 2018 and held it in 11 quarters.
  • Susquehanna International Group's enVVeno Medical position peaked at $318K in Q3 2023.
  • 17 funds tracked by Wall St. Rank held enVVeno Medical as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.